Testing effectiveness (Phase 2)Study completedNCT00622193
What this trial is testing
Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer
Who this might be right for
Carcinoma, Non-Small-Cell Lung
Helsinn Therapeutics (U.S.), Inc 228